MORABITO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 394
EU - Europa 383
AS - Asia 53
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 833
Nazione #
US - Stati Uniti d'America 394
IE - Irlanda 147
SE - Svezia 116
IT - Italia 86
CN - Cina 38
IN - India 12
AT - Austria 8
BE - Belgio 8
GB - Regno Unito 8
DE - Germania 3
CH - Svizzera 2
ID - Indonesia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CO - Colombia 1
FR - Francia 1
RO - Romania 1
TR - Turchia 1
UA - Ucraina 1
Totale 833
Città #
Dublin 147
Chandler 146
Nyköping 67
Ashburn 43
Medford 17
Princeton 17
Beijing 16
Des Moines 13
Ann Arbor 11
Dearborn 11
Pune 11
Brussels 8
Vienna 8
Jacksonville 6
New York 6
Palermo 5
Rome 5
Catania 4
Florence 4
Jinan 4
San Mateo 4
Wilmington 4
Bremen 3
Caltagirone 3
Cambridge 3
Citta 3
Messina 3
Thiene 3
Zumpano 3
Bisignano 2
Bologna 2
Cosenza 2
Hebei 2
Houston 2
Jakarta 2
Lamézia 2
Minneapolis 2
Redwood City 2
Seattle 2
Shenyang 2
Turin 2
Washington 2
Anzio 1
Arzano 1
Birmingham 1
Bogotá 1
Castelnuovo Rangone 1
Duncan 1
Falls Church 1
Fiumefreddo di Sicilia 1
Fuzhou 1
Guangzhou 1
Haikou 1
Istanbul 1
Lanzhou 1
Maceió 1
Milan 1
Montecorice 1
Nanchang 1
Nanjing 1
Napoli 1
Norwalk 1
Santa Venerina 1
Shanghai 1
Taiyuan 1
Zafferana Etnea 1
Zhengzhou 1
Totale 629
Nome #
Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case 84
Cardiobacterium hominis and endocarditis. Rare but important clinical relevance. 70
EFFECT OF 1-YEAR SACUBITRIL-VALSARTAN TREATMENT ON MYOCARDIAL DEFORMATION AND LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CONGESTIVE HEART FAILURE 60
Takotsubo syndrome: prognostic predictors 57
29. How to safely manage delivery of a pregnant woman with congenital AV block? 54
Effect of 1-year sacubitril-valsartan treatment on myocardial deformation and left ventricular ejection fraction in patients with congestive heart failure 51
Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients 49
Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study. 47
null 44
Sacubitril/Valsartan and implantable cardioverter-defibrillators: evolving therapeutic strategies. A case report 44
Takotsubo Cardiomyopathy: a benign condition or a bad omen? 43
Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience. 43
How to safely manage delivery of a pregnant woman with congenital AV block? 42
An “ordinary” case of COVID-19 pneumonia: when symptoms hide serious complications 40
Early antithrombotic therapy and COVID-19: a better clinical course? New evidences from real-life cases 37
The thromboembolism in COVID-19: the unsolved problem 35
Patent foramen ovale and paradoxical coronary artery embolism: rare event with great clinical relevance 35
Cardiovascular risk in psoriasis: current state of the art 27
PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY 21
Totale 883
Categoria #
all - tutte 3.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202054 1 0 0 0 4 3 6 2 0 16 11 11
2020/202181 2 2 7 6 21 12 3 10 5 5 5 3
2021/2022166 0 10 19 6 8 0 6 9 3 44 5 56
2022/2023458 32 56 20 45 24 44 9 27 188 2 6 5
2023/2024108 8 19 3 8 10 35 4 18 0 3 0 0
Totale 883